Lymphoma

Product Candidate / Program Drug substance Indication Discovery Pre-clinical Phase I Phase II Phase III / Pivotal EMA/FDA REVIEW
eryaspase Asparaginase
NH-Lymphoma    

We are investigating the possibility to conduct clinical trials in one or more Non-Hodgkin Lymphoma (NHL) indications.

Top